NRAS and melanoma: Some of the most commonly observed oncogenic events in melanoma are activating mutations of the oncogenic neuroblastoma RAS viral oncogene homolog (NRAS; typically NRASQ61K/R), which occur in 20% of cases (Miller and Mihm, 2006; Tsao et al., 2012).